Annis Gardner Whiting Capital Advisors, LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1998414
TAMPA, FL
Position in ARWR
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$5,016
-$295 QoQ
Shares Held
80
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Annis Gardner Whiting Capital Advisors, LLC holds $3,719,923 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
12,801 | $1,014,991 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,953 | $970,113 | |
| 3 | MRNA |
Moderna, Inc.
|
11,813 | $827,264 | |
| 4 | IOVA |
Iovance Biotherapeutics, Inc.
|
100,470 | $417,955 | |
| 5 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
60,000 | $396,600 | |
| 6 | EVAX |
Evaxion A/S
|
30,000 | $93,000 |
All Filings in ARWR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,016 | 80 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,311 | 80 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,759 | 80 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,264 | 80 | Shares | Sole | 2025-08-11 | |
| 2024-06-30 | $753 | 29 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $829 | 29 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $887 | 29 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $779 | 29 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||